Clinical Trial Update: A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing two dry powder inhalers delivering 400 mcg mometasone furoate shows equivalent effectiveness in moderate asthma; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mometasone furoate (Mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 4 | Status: COMPLETED | Results posted: 2010-03-23